Medical News

< back to feeds
Allergy News
Sweet! Sugared Polymer A New Weapon Against Allergies And Asthma
Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. Their advance is a significant step toward crafting pharmaceuticals to fight these often life-endangering conditions in a new way. For more than a decade, a team led by Bruce S. Bochner, M.D. ...more
21 Nov 2009
Have Egg Allergy? You May Still Be Candidate For Flu Vaccines, Says Allergist
As flu season got underway this fall, Dr. Catherine Monteleone, an allergist, noticed that her office started to receive an unusually high number of calls from people with egg allergy. They previously had avoided flu vaccines because of their sensitivity to eggs. This year, with all the attention being paid to the novel H1N1 influenza, those patients want to be protected against flu, and they contacted her to find out if they are candidates for inoculation. ...more
19 Nov 2009
Annals Of Allergy, Asthma And Immunology To Be Published By Elsevier
Elsevier is pleased to announce that beginning with Volume 104 (2010) it will assume publication of the Annals of Allergy, Asthma & Immunology, the official journal of the American College of Allergy, Asthma & Immunology (ACAAI). The i>Annals of Allergy, Asthma & Immunology, published since 1942, will continue under the leadership of Editor Gailen D. Marshall, MD, PhD and a distinguished editorial board. ...more
18 Nov 2009
Compound Created That Boosts Anti-Inflammatory Fat Levels
UC Irvine pharmacology researchers have discovered a way to boost levels of a natural body fat that helps decrease inflammation, pointing to possible new treatments for allergies, illnesses and injuries related to the immune system. For decades, it has been known that this fat, called palmitoylethanolamide (PEA), is a potent anti-inflammatory substance that reduces both allergic symptoms and occurrences of rheumatic fever, but researchers understood little about how PEA works. ...more
17 Nov 2009
Evidence Of Food Allergies Growing Among Children
Food allergy is a serious and sometimes life-threatening health issue that is increasing among children of all ages, races and ethnicities. Reports indicate that food allergies, especially peanut allergies, are growing, but there is limited knowledge about diagnosis and treatment on a national basis. "Food Allergy Among Children in the United States," published in the December issue of Pediatrics (appearing online Nov. ...more
17 Nov 2009
Does Your Job Make You Itch And Wheeze?
Occupational contact dermatitis and asthma are two of the most common work-related health issues facing workers worldwide, according to experts presenting the latest research at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla. "In many countries, occupational contact dermatitis ranks first among occupational diseases," said Donald Belsito, M.D. ...more
11 Nov 2009
Phadia Introduces New Food Allergy Diagnostic Tools To Meet The Needs Of Allergists
Today at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology, Phadia US introduced two new products designed specifically to meet the unique needs of the nation's 6,000 allergists. ImmunoCAP ISAC and ImmunoCAP HR are new offerings designed to augment traditional allergy testing methodologies and enable diagnosis of complex food allergies at the molecular level, available through its own PiRL testing facility. ...more
11 Nov 2009
Treatment Of Allergic Rhinitis Improves Coexisting Diseases
The treatment of allergic rhinitis is shown to improve co-existing conditions including conjunctivitis, asthma, sinusitis, otitis media with effusion (fluid in the middle ear) and sleep disorders according to an international expert at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla. ...more
10 Nov 2009
New Human Immunology Research Awards To Help Fight Emerging Infectious Diseases Announced By NIAID
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $208 million to two programs that support research to better understand the human immune response to emerging and re-emerging infectious diseases, including those that may be introduced into a community through acts of bioterrorism. ...more
10 Nov 2009
NIAID Awards Five-Year, $56 Million Contract To Continue Study Of Asthma In Inner-city Children
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has renewed the contract to continue studying asthma in children living in lower-income, inner-city environments. ...more
10 Nov 2009
New Developments Improve Food Allergy Management
Less restrictive dietary options, better detection, targeted avoidance measures, educational directives and potential new therapies are improving food allergy management and giving hope to the more than 12 million Americans affected according to experts at the thirteenth international food allergy conference held during the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla. ...more
10 Nov 2009
Interstitial Macrophages: Immune Cells That Prevent Asthma
Microbe-derived molecules able to stimulate the immune system are omnipresent in the air, and the presence of one such molecule (LPS) promotes asthma in some individuals. What prevents inhalation of LPS from promoting asthma in the majority of individuals is not well understood. However, Fabrice Bureau and colleagues, at the University of Liège, Belgium, have now ascribed this function in mice to a population of lung immune cells known as lung interstitial macrophages (IMs). ...more
10 Nov 2009
Researchers Discover Immune Cells That Prevent Asthma In Mice
Researchers in Belgium have discovered that a type of immune cell previously not well understood helped mice from developing an allergic reaction to certain airborne particles that can trigger asthma: they suggest these cells, called lung interstitial macrophages (IMs), may have the same effect in humans. ...more
10 Nov 2009
Asthmatx Presents Impact Of Bronchial Thermoplasty On Allergy Practices At ACAAI Annual Meeting
Asthmatx, Inc. presented the results of a series of studies investigating the effectiveness and safety of bronchial thermoplasty delivered by the Alair® System, and how this new procedure will impact allergy practices, this past weekend in a poster at the 2009 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI), in Miami Beach, Fla. ...more
10 Nov 2009
ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data At The 2009 Annual Meeting Of The American College Of Allergy, Asthma & Immunology (ACAAI)
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), announced additional results from the Company's Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% Phase 3 clinical studies. These results were presented in poster sessions at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) in Miami Beach, FL. In a poster presentation titled, "Treatment of Ocular Itching with Bepotastine Besilate Ophthalmic Solution 1. ...more
10 Nov 2009
Big Air Pollution Impacts On Local Communities
Heavy traffic corridors in the cities of Long Beach and Riverside are responsible for a significant proportion of preventable childhood asthma, and the true impact of air pollution and ship emissions on the disease has likely been underestimated, according to researchers at the University of Southern California (USC). ...more
05 Nov 2009
Potential Allergen In H1N1 Swine Flu Vaccine May Put Children At Risk-Only Phadia Reveals Both Presence And Severity Of The Allergy
The World Health Organization recently declared H1N1 swine flu a global pandemic, resulting in the creation of rigorous vaccination programs worldwide. Children are among those considered particularly susceptible to contracting swine flu and are viewed as a top priority in receiving this vaccine. Most H1N1 swine flu vaccines are prepared from virus grown in chicken's eggs, resulting in a vaccine that contains remnants of egg proteins. ...more
05 Nov 2009
New Asthma Research Presented At CHEST 2009
Zinc Deficiency May Contribute to Allergic Asthma (#8362) Zinc deficiency may play a role in the development of extrinsic or allergic asthma. Researchers from India evaluated serum zinc levels and absolute eosinophil count in 96 cases of asthma (61 patients had intrinsic asthma and 35 had extrinsic asthma). Patients who suffered from any comorbid illness were excluded from the study. ...more
04 Nov 2009
Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint In A Study Of Adult Subjects With A History Of Grass Pollen Allergies
Schering-Plough Corporation (NYSE: SGP) announced that its investigational sublingual Grass (Phleum Pratense) Allergy Immunotherapy Tablet (AIT) has met the primary endpoint in a Phase III study of adult subjects in the U.S. with a history of grass pollen induced rhinoconjunctivitis with or without asthma. ...more
03 Nov 2009
Dey Launches And Unveils Next-Generation, Needle-Protected EpiPen(R) (Epinephrine) Auto-Injector With Enhanced Patient-Friendly Features
Dey Pharma, L.P., a subsidiary of Mylan Inc. (Nasdaq: MYL - News), launched a newly designed, patient-friendly EpiPen® Auto-Injector 0.3/0.15 mg. This next-generation EpiPen Auto-Injector maintains the simplicity, speed, safety and reliability of EpiPen Auto-Injector with several new, user-friendly features, including being the only auto-injector with needle-protection before and after use. Dey President Carolyn Myers, Ph.D. ...more
29 Oct 2009

Pages of Results:   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 [Next] [Last Page]
Allergy News courtesy of Medical News Today back to top